Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

9.27

-0.96 (-9.38%)

At close: Jul 29, 2025, 4:00 PM

9.53

+0.26 (2.80%)

Pre-market: Jul 30, 2025, 8:58 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Therapeutics for the Treatment of Metabolic Dysfunction-associated Steatohepatitis and Other Diseases	2.00M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	2.00M